Advertisement

Topics

J&J cancer drug patent invalidated by U.S. court, hitting UK's BTG

05:32 EST 18 Jan 2018 | Fox Business

Johnson & Johnson's patent on its prostate cancer drug Zytiga was invalidated by a U.S. judge, bringing rivals closer to selling generic versions.

Original Article: J&J cancer drug patent invalidated by U.S. court, hitting UK's BTG

NEXT ARTICLE

More From BioPortfolio on "J&J cancer drug patent invalidated by U.S. court, hitting UK's BTG"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...